Spyre Therapeutics
SYRE | NASDAQ
$99.37
-$4.63 (-4.45%)
At close: Nov 16, 2026, 4:00 PM ET
$99.37
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Spyre Therapeutics Cash Flow Statement
Cash flow statement explainedTTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -263.86M | -178.92M | -179.44M | -155.2M | -148.97M | -206.81M | -208.93M | -208.02M | -214.9M | -185.98M | -364.23M | -338.79M | -294.43M | -272.56M | -77.8M | -83.82M | -85.44M | -87.51M | -72.02M | -65.8M | -68.07M | -65.8M | -80.38M | |
| – | – | – | – | – | – | – | – | -220K | -220K | 196K | 744K | 1.35M | 1.85M | 1.91M | 1.77M | 1.79M | 1.7M | 1.62M | 1.58M | 1.53M | 1.37M | 1.2M | |
| 50.3M | 45.7M | 41.56M | 37.61M | 37.02M | 40.55M | 39.86M | 44.83M | 52.89M | 44.57M | 37.8M | 25.68M | 9.83M | 6.61M | 6.72M | 7.11M | 7.78M | 8.32M | 8.38M | 8.04M | 7.56M | 7.15M | 6.67M | |
| -3.9M | -6.47M | -6.57M | -15.53M | 18.87M | 25.1M | -1.63M | 11.68M | -20.68M | -37.49M | 4.93M | -5.64M | -2.51M | 4.99M | -2.22M | -3.3M | -8.32M | -6.6M | -21.44M | 768K | 7.24M | 6.77M | 21.19M | |
| -33.35M | -70.71M | -42.63M | -45.73M | -57.05M | 544K | 7.79M | 10.31M | 29.89M | 22.41M | 217.49M | 219.37M | 200.74M | 192.03M | 115K | 298K | 456K | 782K | 601K | 638K | 557K | 313K | 398K | |
| – | – | – | – | – | – | – | – | -1.71M | -1.71M | -1.71M | -1.71M | – | – | – | – | – | – | – | – | – | – | – | |
| -2.41M | -5.01M | -5.12M | -5.93M | 7.13M | 11.54M | -8.58M | -4.53M | -17.2M | -35.5M | -369K | -5.21M | -4.5M | 4.58M | -2.46M | -5.5M | -5.86M | -6.49M | 963K | 1.83M | 6.84M | 4.85M | -1.49M | |
| -249.32M | -208.94M | -185.63M | -169.25M | -161.87M | -154.18M | -169.86M | -157.41M | -151.25M | -156.42M | -110.82M | -99.91M | -87.01M | -67.49M | -71.52M | -80.14M | -81.27M | -83.2M | -60.45M | -53.72M | -51.58M | -52.12M | -73.61M | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -1K | -1K | -38K | -38K | -130K | -160K | -573K | -1.57M | -2.05M | -3.34M | |
| – | – | – | – | – | – | – | – | -15.48M | -15.48M | -15M | -15M | 475K | 475K | – | – | – | – | – | – | – | – | – | |
| -1.01B | -944.41M | -531.94M | -522.21M | -413.6M | -374.46M | -517.98M | -599.25M | -420.33M | -497.91M | -319.52M | -166.8M | -117.13M | -11.75M | -36M | -39.5M | -48.25M | -67.25M | -112.33M | -133.08M | -150.83M | -147.08M | -149.25M | |
| 445.96M | 410.68M | 408.1M | 371.74M | 339.99M | 318.59M | 269.6M | 245.97M | 202.32M | 124.53M | 69.9M | 39.9M | 39.5M | 63.25M | 85M | 96.55M | 100.96M | 109.33M | 106.33M | 111.03M | 148.74M | 145.47M | 139.53M | |
| 70M | 70M | 37M | 7M | 7M | 7M | – | – | 15.48M | 30.48M | 33.51M | 33.51M | 18.04M | 3.04M | – | – | – | – | – | – | – | – | – | |
| -492.54M | -463.74M | -86.83M | -143.48M | -66.61M | -48.87M | -248.38M | -353.29M | -218.01M | -358.38M | -231.11M | -108.39M | -59.12M | 55.01M | 49M | 57.01M | 52.67M | 41.95M | -6.16M | -22.62M | -3.66M | -3.66M | -13.06M | |
| – | – | – | – | – | – | – | – | – | – | -8K | -16K | -24K | -87K | -254K | -418K | -579K | -624K | -677K | -510K | -347K | -245K | -18K | |
| – | – | – | -117K | -117K | -117K | -117K | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -56.72M | -28.75M | -5.49M | -5.08M | -4.03M | 2.34M | 172.16M | 5.67M | -1.09M | -2.23M | -171.93M | -5.66M | 123K | 56K | 43.04M | 43.2M | 43.45M | 44.66M | 1.72M | 1.9M | 1.73M | 886K | 894K | |
| 759.69M | 753.03M | 321.16M | 309.03M | 221.81M | 239.24M | 238.87M | 410.91M | 348.91M | 323.6M | 533.23M | 361.08M | 197.46M | 209.86M | 42.68M | 42.68M | 42.77M | 44.04M | 1.04M | 1.39M | 25.99M | 25.11M | 154.59M | |
| 17.83M | 80.35M | 48.69M | -3.7M | -6.68M | 36.19M | -179.38M | -99.79M | -20.32M | -191.21M | 191.32M | 152.8M | 51.38M | 197.4M | 20.09M | 19.44M | 14.02M | 2.66M | -65.61M | -74.96M | -29.22M | -30.6M | 67.98M | |
| -249.32M | -208.94M | -185.63M | -169.25M | -161.87M | -154.18M | -169.86M | -157.41M | -151.25M | -156.42M | -110.82M | -99.91M | -87.01M | -67.49M | -71.52M | -80.18M | -81.31M | -83.33M | -60.61M | -54.29M | -53.15M | -54.16M | -76.95M | |
| -299.62M | -254.64M | -227.19M | -206.87M | -198.89M | -194.73M | -209.72M | -202.24M | -204.13M | -201M | -148.62M | -125.59M | -96.85M | -74.1M | -78.24M | -87.29M | -89.09M | -91.65M | -68.99M | -62.33M | -60.71M | -61.31M | -83.62M | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -1K | -1K | -1K | -1K | – | – | -450K | -1.45M | -2.02M | -3.34M | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -37K | -37K | -130K | -160K | -123K | -123K | -30K | – | |
| -249.32M | -208.94M | -185.63M | -169.25M | -161.87M | -154.18M | -169.86M | -157.41M | -151.25M | -156.42M | -110.82M | -99.91M | -87.01M | -67.49M | -71.52M | -80.15M | -81.27M | -83.2M | -60.45M | -54.17M | -53.03M | -54.13M | -76.95M |
Add to Watchlist
Select watchlists to add or remove SYRE